Revisiting the concept of hepatosplenic schistosomiasis and its challenges using traditional and new tools

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 47, Issue 2, 2014, Pages 130-136

  Lambertucci, José Roberto ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Hepatosplenic schistosomiasis; Magnetic resonance imaging; Manson's schistosomiasis; Thrombocytopenia; Ultrasound

Indexed keywords

BIOLOGICAL MARKER;

BLOOD CELL COUNT; DIGESTIVE SYSTEM HEMORRHAGE; ECHOGRAPHY; FECES ANALYSIS; HEPATOMEGALY; HEPATOSPLENIC SCHISTOSOMIASIS; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PALPATION; PULMONARY HYPERTENSION; REVIEW; SCHISTOSOMIASIS; SCHISTOSOMIASIS MANSONI; SPLENOMEGALY; THROMBOCYTOPENIA;

ANIMALS; BIOLOGICAL MARKERS; FECES; HUMANS; LIVER DISEASES, PARASITIC; MAGNETIC RESONANCE IMAGING; SCHISTOSOMIASIS MANSONI; SEVERITY OF ILLNESS INDEX; SPLENIC DISEASES;

EID: 84901285697     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/0037-8682-0186-2013     Document Type: Review

References (82)

1. Kierkegaard S. The concept of irony with constant reference to Socrates. New York, USA: Harper & Row Publishers; 1965.
2. Symmers WSC. Note on a new form of liver cirrhosis due to the presenceof the ova of Bilharzia haematobia. J Pathol Bacteriol 1904; 9: 237-239.
3. Bogliolo L. The anatomical picture of the liver in hepatosplenicschistosomiasis mansoni. An Trop Med Parasitol 1957; 51: 1-14.
4. Rebouças G. Clinical aspects of hepatosplenic schistosomiasis. A contrastwith cirrhosis. Yale J Biol Med 1975; 48: 369-376.
5. Andrade ZA. Schistosomal hepatopathy. Mem Inst Oswaldo Cruz 2004; 99 (suppl I): 51-57.
6. Warren KS The kinetics of hepatosplenic schistosomiasis. Semin LiverDis 1984; 4: 293-300.
7. Bedossa P, Carrat F. Liver biopsy: the best, not the gold standard. J Hepatol 2009; 50: 1-3.
8. Dusek J, Kubasta M, Kodousek R, Kubastova B. Needle biopsy of theliver in shistosomiasis mansoni: the value of histological examination. J Trop Med Hyg 1965; 68: 189-195.
9. Lambertucci JR, Rocha RS, Carvalho OS, Katz N. A esquistossomosemansoni em Minas Gerais. Rev Soc Bras Med Trop 1987; 20: 47-52.
10. Lambertucci JR. Schistosoma mansoni: pathological and clinical aspects. In: Jordan P, Webbe G, Sturrock RF, editors. Oxon, UK: Cab InternationalWallingford; 1993. p. 195-235.
11. Elbaz T, Esmat G. Hepatic and intestinal schistosomiasis: review. J AdvRes 2013; 4: 445-452.
12. Barsoum RS, Esmat G, Elbaz T. Human schistosomiasis: Clinicalperspective. J Adv Res 2013; 4: 433-444.
13. Lambertucci JR, Voieta I, Resende V. Slight, moderate and intenseSymmers's fibrosis in hepatosplenic schistosomiasis mansoni. Rev SocBras Med Trop 2009; 42: 611-612.
14. Prata A, Ruiz-Guevara R, Antunes CM, Marinho CC, Queiroz LC, Voieta I, et al. Comparison between clinical and ultrasonographic findings in casesof periportal fibrosis in an endemic area for schistosomiasis mansoni inBrazil. Rev Soc Bras Med Trop 2010; 43: 129-134.
15. Lambertucci JR, Cota GF, Pinto-Silva RA, Serufo JC, Gerspacher-Lara R, Costa Drummond S, et al. Hepatosplenic schistosomiasis in field-basedstudies: a combined clinical and sonographic definition. Mem InstOswaldo Cruz 2001; 96 (suppl I): 147-150.
16. Kloetzel K. Splenomegaly in schistosomiasis mansoni. Am J Trop Med1962; 11: 472-476.
17. Gerspacher-Lara R, Pinto-Silva RA, Serufo JC, Rayes AA, Drummond SC, Lambertucci JR. Spleen palpation for the evaluation of morbidity due toschistosomiasis mansoni. Mem Inst Oswaldo Cruz 1998; 93 (suppl I): 245-248.
18. Silva LC, Carrilho FJ. Hepatosplenic schistosomiasis: pathophysiologyand treatment. Gastroenterol Clin North Am 1992; 21: 163-177.
19. Brandt CT, Domingues ALC, Vilela P, Sena A, Marques K, Giusti CF. Histomorphometry of hepatic portal fibrosis in patients with surgicalschistosomiasis mansoni. Acta Cir Bras 2002; 17 (suppl I): 7-10.
20. Mies S, Neto OB, Beer Jr A, Baía CE, Alfieri Jr F, Pereira LM, et al. Systemic and hepatic hemodynamics in hepatosplenic Manson'sschistosomiasis with and without propranolol. Dig Dis Sci 1997; 42: 751-761.
21. Raia S, Mies S, Alfieri Júnior F. Portal hypertension in mansonicschistosomiasis. World J Surg 1991; 15: 176-187.
22. Strauss E, Costa Gayotto LC, Antonelli R, Deperon S, Cabral GL, Raia S. Systemic surgical shunts and splenomegaly as causes of haemolysis inportal hypertension in mansonic schistosomiasis. Evaluation throughserum levels of haptoglobin, hemopexin and bilirubins. J Hepatol 1986; 2: 340-350.
23. Abdel-Wahab MF, Esmat G, Milad M, Abdel-Razek S, Strickland GT. Characteristic sonographic pattern of schistosomal hepatic fibrosis. Am JTrop Med Hyg 1989; 40: 72-76.
24. Hatz C. Use of ultrasound. In: Jordan P, Webbe G, Sturrock RF, editors. Oxon, UK: Cab International Wallingford; 1993. p. 305-329.
25. Pinto-Silva RA, Queiroz LC, Azeredo LM, Silva LC, Lambertucci JR. Ultrasound in schistosomiasis mansoni. Mem Inst Oswaldo Cruz 2010; 105: 479-484.
26. Richter J, Domingues AL, Barata CH, Prata AR, Lambertucci JR. Reportof the second satellite symposium on ultrasound in schistosomiasis. MemInst Oswaldo Cruz 2001; 96 (suppl I): 151-156.
27. Prata A, Andrade ZA. Fibrose hepática de Symmers sem esplenomegalia. Hospital 1963; 63: 617-623.
28. Petroianu A. Tratamento cirúrgico da hipertensão porta na esquistossomosemansoni. Rev Soc Bras Med Trop 2003; 36: 253-265.
29. Homeida MA, Abdel-Gadir AF, Cheever AW, Bennett JL, Arbab BMO, Ibrahim SZ, et al. Diagnosis of pathologically confirmed Symmers'periportal fibrosis by ultrasonography: a prospective blinded study. Am JTrop Med Hyg 1988; 38: 86-91.
30. Lambertucci JR, Serufo JC, Gerspacher-Lara R, Rayes AA, Teixeira R, Nobre V, Antunes CM. Schistosoma mansoni: assessment of morbiditybefore and after control. Acta Trop 2000; 77: 101-109.
31. Cota GF, Pinto-Silva RA, Antunes CM, Lambertucci JR. Ultrasound andclinical investigation of hepatosplenic schistosomiasis: evaluation ofsplenomegaly and liver fibrosis four years after mass chemotherapy withoxamniquine. Am J Trop Med Hyg 2006; 74: 103-107.
32. Lambertucci JR, Gerspacher-Lara R, Pinto-Silva RA, Barbosa MM, Teixeira R, Barbosa HF, et al. The Queixadinha Project: morbidity andcontrol of schistosomiasis in an endemic area in the northeast of MinasGerais, Brazil. Rev Soc Bras Med Trop 1996; 29: 127-135.
33. Lambertucci JR. Acute schistosomiasis: clinical, diagnostic andtherapeutic features. Rev Inst Med Trop Sao Paulo 1993; 35: 399-404.
34. Lambertucci JR. Acute schistosomiasis mansoni: revisited andreconsidered. Mem Inst Oswaldo Cruz 2010; 105: 422-435.
35. Lambertucci JR, Drummond SC, Voieta I, Queiróz LC, Pereira PP, Chaves BA, et al. An outbreak of acute Schistosoma mansoni Schistosomiasisin a nonendemic area of Brazil: a report on 50 cases, including 5 with severeclinical manifestations. Clin Infect Dis 2013; 57: e1-e6.
36. Silva LC, Andrade LM, Paula IB, Queiroz LC, Antunes CM, Lambertucci JR. Ultrasound and magnetic resonance imaging findingsin schistosomiasis mansoni: expanded gallbladder fossa and fatty hilumsigns. Rev Soc Bras Med Trop 2012; 45: 500-504.
37. Silva LC, Pereira AC, Queiroz LC, Andrade LM, Antunes CM, Lambertucci JR. Disagreement between ultrasound and magneticresonance imaging in the identification of schistosomal periportal fibrosis. Mem Inst Oswaldo Cruz 2006; 101(suppl I): 279-282.
38. Voieta I, Queiroz LC, Andrade LM, Silva LC, Fontes VF, Barbosa Jr A, et al. Imaging techniques and histology in the evaluation of liver fibrosisin hepatosplenic schistosomiasis mansoni in Brazil: a comparative study. Mem Inst Oswaldo Cruz 2010; 105: 414-421.
39. Voieta I, Andrade LM, Lambertucci JR. Magnetic resonance of the liverin acute schistosomiasis. Rev Soc Bras Med Trop 2011; 44: 403.
40. Lambertucci JR, Silva LC, Andrade LM, Queiroz LC, Carvalho VT, Voieta I, et al. Imaging techniques in the evaluation of morbidity inschistosomiasis mansoni. Acta Trop 2008; 108: 209-217.
41. Silva LC, Andrade LM, Queiroz LC, Voieta I, Azeredo LM, Antunes CM, Lambertucci JR. Schistosoma mansoni: magnetic resonance analysisof liver fibrosis according to WHO patterns for ultrasound assessmentof schistosomiasis-related morbidity. Mem Inst Oswaldo Cruz 2010; 105: 467-470.
42. Lambertucci JR, Silva LC, Andrade LM, Queiroz LC, Pinto-Silva RA. Magnetic resonance imaging and ultrasound in hepatosplenicschistosomiasis mansoni. Rev Soc Bras Med Trop 2004; 37: 333-337.
43. Bezerra AS, D'Ippolito G, Caldana RP, Cecin AO, Ahmed M, Szejnfeld J. Chronic hepatosplenic schistosomiasis mansoni: magnetic resonanceimaging and magnetic resonance angiography findings. Acta Radiol2007; 48: 125-134.
44. Grigorescu M. Noninvasive biochemical markers of liver fibrosis. J Gastrointestin Liver Dis 2006; 15: 149-159.
45. Liu T, Wang X, Karsdal MA, Leeming DJ, Genovese F. Molecular serummarkers of liver fibrosis. Biomark Insights 2012; 7: 105-117.
46. Marinho CC, Bretas T, Voieta I, Queiroz LC, Ruiz-Guevara R, Teixeira AL, et al. Serum hyaluronan and collagen IV as non-invasive markers of liverfibrosis in patients from an endemic area for schistosomiasis mansoni: afield-based study in Brazil. Mem Inst Oswaldo Cruz 2010; 105: 471-478.
47. Pereira TA, Xie G, Choi SS, Syn WK, Voieta I, Lu J, et al. MacrophagederivedHedgehog ligands promotes fibrogenic and angiogenic responsesin human schistosomiasis mansoni. Liver Int 2013; 33: 149-161.
48. Barbosa MM, Lamounier JA, Oliveira EC, Souza MV, Marques DS, Silva AA, et al. Pulmonary hypertension in schistosomiasis mansoni. Trans R Soc Trop Med Hyg 1996; 90: 663-665.
49. Butrous G, Ghofrani HA, Grimminger F. Pulmonary vascular disease inthe developing world. Circulation 2008; 118: 1758-1766.
50. Lambertucci JR, Prata PH, Voieta I. Left recurrent laryngeal palsy(Ortner's syndrome) in schistosomal pulmonary hypertension. Rev SocBras Med Trop 2010; 43: 608.
51. Carvalho VT, Barbosa MM, Nunes MC, Cardoso YS, Sá Filho IM, Oliveira FR, et al. Early right cardiac dysfunction in patients withschistosomiasis mansoni. Echocardiography 2011; 28: 261-267.
52. Lambertucci JR, Carvalho VT, Silva LC. Pulmonary hypertension inschistosomiasis mansoni. Rev Soc Bras Med Trop 2006; 39: 295-296.
53. Morrell NW, Archer SL, Defelice A, Evans S, Fiszman M, Martin T, et al. Anticipated classes of new medications and molecular targets forpulmonar arterial hypertension. Pulm Circ 2013; 3: 226-244.
54. Tackett KL, Stajich GV. Combination pharmacotherapy in the treatmentof pulmonary arterial hypertension: continuing education article. J PharmPract 2013; 26: 18-28.
55. Buckley MS, Staib RL, Wicks LM. Combination therapy in themanagement of pulmonary arterial hypertension. Int J Clin Pract Suppl2013; 179: 13-23.
56. Rodrigues VL, Otoni A, Voieta I, Antunes CM, Lambertucci JR. Glomerulonephritis in schistosomiasis mansoni: a time to reappraise. RevSoc Bras Med Trop 2010; 43: 638-642.
57. Lambertucci JR, Godoy P, Neves J, Bambirra EA, Ferreira MD. Glomerulonephritis in Salmonella-Schistosoma mansoni association. AmJ Trop Med Hyg 1988; 38: 97-102.
58. Braga BP, Costa Junior LB, Lambertucci JR. Magnetic resonanceimaging of cerebellar schistosomiasis mansoni. Rev Soc Bras Med Trop2003; 36: 635-636.
59. Manzella A, Borba-Filho P, Brandt CT, Oliveira K. Brain magneticresonance imaging findings in young patients with hepatosplenicschistosomiasis mansoni without overt symptoms. Am J Trop Med Hyg2012; 86: 982-987.
60. Felipe L, Gonçalves DU, Tavares MC, Sousa-Pereira SR, Antunes CM, Lambertucci JR. Vestibular-evoked myogenic potential (VEMP) in theevaluation of schistosomal myeloradiculopathy. Am J Trop Med Hyg2009; 81: 551-554.
61. Lambertucci JR, Silva LC, Amaral RS. Guidelines for the diagnosis andtreatment of schistosomal myeloradiculopathy. Rev Soc Bras Med Trop2007; 40: 574-581.
62. Vale TC, Sousa-Pereira SR, Ribas JG, Lambertucci JR. Neuroschistosomiasis mansoni: literature review and guidelines. Neurologist 2012; 18: 333-342.
63. Lambertucci JR, Teixeira R, Navarro MM, Coelho PM, Ferreira MD. Liver abscess and schistosomiasis. A new association. Rev Soc Bras MedTrop 1990; 23: 239-240.
64. Lambertucci JR, Rayes AA, Serufo JC, Nobre V. Pyogenic abscesses andparasitic diseases. Rev Inst Med Trop Sao Paulo 2001; 43: 67-74.
65. Feldmeier H, Daccal RC, Martins MJ, Soares V, Martins R. Genitalmanifestations of schistosomiasis mansoni in women: important butneglected. Mem Inst Oswaldo Cruz 1998; 93 (suppl I): 127-133.
66. Lambertucci JR, Villamil QT, Savi D, Dias IC. Genital schistosomiasismansoni: tubal tumor and parietal peritoneum involvement diagnosedduring laparoscopy. Rev Soc Bras Med Trop 2009; 42: 583-586.
67. Lambertucci JR, Voieta I, De Brot M. Vulvar schistosomiasis mansoni. Rev Soc Bras Med Trop 2008; 41: 435-436.
68. Lambertucci JR, Voieta I, Barbosa AJ. Schistosomiasis mansoni of theprostate. Rev Soc Bras Med Trop 2006; 39: 233-234.
69. Souza MR, Toledo CF, Borges DR. Thrombocytemia as a predictor ofportal hypertension in schistosomiasis. Dig Dis Sci 2000; 45: 1964-1970.
70. Lambertucci JR, Silva LC, Antunes CM. Aspartate aminotransferase toplatelet ratio index and blood platelet count are good markers for fibrosisevaluation in schistosomiasis mansoni. Rev Soc Bras Med Trop 2007; 40: 599.
71. Lambertucci JR, Duani H, Prata PH, Voieta I. Pseudothrombocytopenia inschistosomiasis mansoni. Rev Soc Bras Med Trop 2011; 44: 792.
72. Maurizio R, Eugenio C, Roberto PR. Results of sclerotherapy forbleeding esophageal varices in patients with schistosomal liver disease. A retrospective study. Hepatogastroenterology 2000; 47: 424-428.
73. Gasim B, Fedail SS, Musaad AM, Salih SM, Ibn-Ouf M. Endoscopicsclerotherapy for bleeding oesophageal varices: experience in Sudan. Trop Gastroenterol 2002; 23: 107-109.
74. Pirajá da Silva MA. Contribuição para o estudo da schistosomíase naBahia. Brasil Médico 1908; 29: 281-283.
75. Prata A. Infl uence of the host-related factors in the development of thehepatosplenic schistosomiasis mansoni. Mem Inst Oswaldo Cruz 1992; 87: 369-376.
76. Avila RE, Batista TS, Xavier MA, Nogueira AM, Lambertucci JR. Schistosomiasis mansoni and severe gastrointestinal cytomegalovirusdisease in a patient with acquired immunodeficiency syndrome. Rev SocBras Med Trop 2006; 39: 379-382.
77. Nobre V, Braga E, Rayes A, Serufo JC, Godoy P, Nunes N, et al. Opportunistic infections in patients with AIDS admitted to a UniversityHospital of the Southeast of Brazil. Rev Inst Med Trop Sao Paulo 2003; 45: 69-74.
78. Lambertucci JR, Rayes AA, Nunes F, Landazuri-Palacios JE, Nobre V. Fever of undetermined origin in patients with the acquiredimmunodeficiency syndrome in Brazil: report on 55 cases. Rev Inst MedTrop Sao Paulo 1999; 41: 27-32.
79. Lambertucci JR, Rayes AA, Serufo JC, Gerspacher-Lara R, BrasileiroFilho G, Teixeira R, et al. Schistosomiasis and associated infections. Mem Inst Oswaldo Cruz 1998; 93 (suppl I): 135-139.
80. Lambertucci JR, Rayes AA, Gerspacher-Lara R. Salmonella-S. mansoniassociation in patients with acquired immunodeficiency syndrome. Rev Inst Med Trop Sao Paulo 1998; 40: 233-235.
81. Serufo JC, Antunes CM, Pinto-Silva RA, Gerspacher-Lara R, Rayes AA, Drummond SC, et al. Chronic carriers of hepatitis B surface antigen in anendemic area for schistosomiasis mansoni in Brazil. Mem Inst OswaldoCruz 1998; 93 (suppl I): 249-253.
82. Abdel-Rahman M, El-Sayed M, El Raziky M, Elsharkawy A, El-Akel W, et al. Coinfection with hepatitis C virus and schistosomiasis: fibrosis andtreatment response. World J Gastroenterol 2013; 19: 2691-2696.